New drug SAT-3247 tested for long-term muscle protection in duchenne MD
Disease control
ENROLLING_BY_INVITATION
This study looks at the long-term safety and effects of a drug called SAT-3247 in 10 people with Duchenne muscular dystrophy who were in a previous trial. Participants take the drug by mouth five days a week for about 11 months. Researchers will check for side effects and measure…
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC